Europe is home to 32% of the world’s quantum tech companies, with the majority based in the EU. This puts Europe ahead of the United States (around 25%) and significantly ahead of China (5%) in terms of the number of companies.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
Here, Dr Carlos Ziebert, Karlsruhe Institute of Technology, discusses progress in battery research through safety and ageing studies using calorimeters.
Kris Bachus and Julie Metta from the HIVA Research Institute of KU Leuven, Belgium, present Pop-Machina, a Horizon 2020 Innovation project that promotes circular maker communities in urban areas.
The new powers to detain and isolate ‘potentially infectious’ people under the Coronavirus Act are alarming enough when applied to adults – but how do they apply to children? John Binns, partner at BCL Solicitors LLP explores here.
Jeremy Shulman, Chief Editor, Subscriptions and Product at Interactive Pro and Edology, advises how one can escape the daily negative news cycle due to Coronavirus and isolation, looking at different aspects including work, learning and how to stay informed.
Lucinda Carney, Chartered Occupational Psychologist and Founder at Actus, discusses the impact that self-isolation has on mental health and how businesses can minimise stress amongst its workforce.
Wellbeing experts at CABA have created a guide to help people spot the signs of autism and highlight what support is on offer to raise awareness on World Autism Day.
